Comirnaty
Drug Infectious Diseases
NDC 0069-2025-25
General payments
$1,600,438,365
Research payments
$8,245,685
Through program year 2023, $1,600,438,365 in general payments and $8,245,685 in research payments were reported against Comirnaty (Infectious Diseases).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $367,540,485 | 15 |
| 2023 | Research | $651,777 | 248 |
| 2022 | General | $716,595,825 | 5 |
| 2022 | Research | $3,465,387 | 560 |
| 2021 | General | $516,302,056 | 7 |
| 2021 | Research | $4,128,520 | 92 |
Breakdown
Records
27 general · 900 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.